Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Sebastian Clauditz

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Gynecologic Oncology|January 12, 2020
High homogeneity of MMR deficiency in ovarian cancerChristoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Biomarker Research|June 6, 2021
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumorsEike Burandt, Felix Lübbersmeyer, Natalia Gorbokon, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
International Journal of Cancer|April 23, 2021
Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targetsLara Bußmann, Konstantin Hoffer, Clara Marie von Bargen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Gynecologic Oncology|January 12, 2020
High homogeneity of MMR deficiency in ovarian cancerChristoph Fraune, Janina Rosebrock, Ronald Simon, et al.
Oncotarget|November 24, 2016
Deletion of 8p is an independent prognostic parameter in prostate cancerMartina Kluth, Nina Nadine Amschler, Rami Galal, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Biomarker Research|June 6, 2021
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumorsEike Burandt, Felix Lübbersmeyer, Natalia Gorbokon, et al.
European Urology|November 7, 2015
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy SpecimensGuido Sauter, Stefan Steurer, Till Sebastian Clauditz, et al.
International Journal of Cancer|April 23, 2021
Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targetsLara Bußmann, Konstantin Hoffer, Clara Marie von Bargen, et al.
Pageof 4